All News

FDA updates Tremfya label in psoriatic arthritis, confirming it slows structural joint damage and helping patients protect mobility while easing symptoms.

Boost patient demand for pharmacist prescribing with clear messaging, service pages, in-store prompts, social posts, and local partnerships.

From supporting MTM services to reaching unhoused populations, the 340B program is a powerhouse for patient care, access, and affordability.

This month’s event will explore policy, people, and profitability, and how pharmacy businesses can transform these factors toward actionable solutions.

New FDA label lets linaclotide treat functional constipation in children 2 to 5, with dosing tips, mixing options, and key safety warnings.

Utah protocol streamlines large-volume immunoglobulin for measles-exposed infants as outbreaks surge.

In part 2, Miller further breaks down the fragmentation of menopause care within today’s health care system and how pharmacists are uniquely positioned to fill in long-standing care gaps.

American College of Cardiology's new postpartum cardiovascular disease pathway urges early follow-up and tighter blood pressure goals.

Across rural US community pharmacies, researchers explore the common barriers and facilitators to pneumococcal vaccine uptake.

Two separate bills were marked up in House committees last week and were officially advanced to potentially move additional PBM reform into law.

CMS pares Medicare Star Ratings, pushing patient-driven outcomes, medication safety, costs, and quality of life, reshaping how Part D plans compete.

Exploring pneumococcal vaccination rates among eligible adult patients, researchers conducted a quality improvement initiative at a clinic in Illinois.

Real-world data show GLP-1 drugs in type 1 diabetes cut heart and kidney risks, support weight loss, and appear safe with insulin adjustments.

Late-phase trials show switching to daily oral orforglipron or lower-dose tirzepatide helps maintain weight loss, easing regain and boosting adherence.

Researchers hope to inform national strategies on pharmacists’ potential place in asthma management.

A new 25-valent pediatric pneumococcal vaccine enters phase 3 after strong data, aiming for broader coverage and improved serotype 3 protection.

The proposed bill would force pharmacy benefit managers to act on the interests of pharmacies rather than their own companies.

Results of Eli Lilly’s investigational triple agonist were reported in the TRIUMPH-1 Phase 3 clinical trial.

New FDA guidance sharpens postmarket pregnancy drug safety data, improving labels and empowering pharmacists to report adverse events.

Although currently contained outside of the US, the Bundibugyo strain of the virus reached an American worker in the Democratic Republic of Congo.

New OASIS 4 data show early oral semaglutide responders hit 21.6% weight loss and improve mobility.

In part 2, Tom DePietro, PharmD, explores emerging topics of interest within community pharmacy, including AI, PBMs, and the industry’s evolving nature.

Heat waves can alter drug safety and storage, and some medicines raise heat risk.

The announcement comes with a partnership with Mark Cuban Cost Plus Drug Company, Amazon Pharmacy, and GoodRx.

With Commissioner Makary resigning just days prior, this marks the second and third major change in the federal agency’s leadership this month.

Between clinical initiatives, educational strategies, and regulatory frameworks, researchers explore PGx services integration.

The approval also includes an interchangeability designation, meaning both products can be substituted at the pharmacy level.

FDA approves Baxfendy, a new oral aldosterone blocker, to help hard-to-control hypertension.